{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:02:07Z","timestamp":1774069327670,"version":"3.50.1"},"reference-count":104,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.antiviral.2010.08.005","type":"journal-article","created":{"date-parts":[[2010,8,14]],"date-time":"2010-08-14T08:52:29Z","timestamp":1281775949000},"page":"129-142","source":"Crossref","is-referenced-by-count":16,"title":["Radiolabeled antiviral drugs and antibodies as virus-specific imaging probes"],"prefix":"10.1016","volume":"88","author":[{"given":"Mike","family":"Bray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Di Mascio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"de Kok-Mercado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Mollura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Jagoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2010.08.005_bib0005","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0969-8051(96)00075-3","article-title":"9-[(3-[18F]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG): a potential imaging agent of viral infection and gene therapy using PET","volume":"23","author":"Alauddin","year":"1996","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2008.01.003","article-title":"Current and future antiviral therapy of severe seasonal and avian influenza","volume":"78","author":"Beigel","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0015","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00134-010-1756-1","article-title":"Imaging of lung inflammation during severe influenza A: H1N1","volume":"36","author":"Bellani","year":"2010","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0020","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1097\/CCM.0b013e3181aab31f","article-title":"Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: a [18F]-fluoro-2-deoxy-D-glucose PET\/CT study","volume":"37","author":"Bellani","year":"2009","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0025","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/89991","article-title":"Positron emission tomography imaging for herpes virus infection: implications for oncolytic viral treatments of cancer","volume":"7","author":"Bennett","year":"2001","journal-title":"Nat. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2010.08.005_bib0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00003088-199936001-00004","article-title":"Deposition and disposition of [11C]zanamivir following administration as an intranasal spray. Evaluation with positron emission tomography","volume":"36","author":"Bergstrom","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0035","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1073\/pnas.0408861102","article-title":"Imaging bacterial infections with radiolabeled 1-(2\u2032-deoxy-2\u2032-fluoro-beta-D-arabinofuranosyl)-5-iodouracil","volume":"102","author":"Bettegowda","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2010.08.005_bib0040","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.antiviral.2005.10.008","article-title":"Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses","volume":"69","author":"Bolken","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0045","doi-asserted-by":"crossref","first-page":"e4789","DOI":"10.1371\/journal.pone.0004789","article-title":"Imaging of lymph node micrometastases using an oncolytic herpes virus and [F]FEAU PET","volume":"4","author":"Brader","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2010.08.005_bib0050","first-page":"581","article-title":"Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3\u2032-azido-2\u2032,3\u2032-dideoxythymidine (AZT, zidovudine): a PET-FDG study","volume":"30","author":"Brunetti","year":"1989","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0055","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/01.aids.0000222070.52996.76","article-title":"Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation","volume":"20","author":"Brust","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2010.08.005_bib0060","first-page":"1621","article-title":"Indium-111-labeled polyclonal human immunoglobulin: identifying focal infection in patients positive for human immunodeficiency virus","volume":"34","author":"Buscombe","year":"1993","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0065","doi-asserted-by":"crossref","first-page":"7721","DOI":"10.1128\/JVI.79.12.7721-7727.2005","article-title":"[18F]FHPG positron emission tomography for detection of herpes simplex virus (HSV) in experimental HSV encephalitis","volume":"79","author":"Buursma","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0070","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.nurt.2007.04.006","article-title":"Positron emission tomography imaging of neuroinflammation","volume":"4","author":"Cagnin","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.antiviral.2010.08.005_bib0075","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1517\/14712598.7.5.595","article-title":"Targeting host cells harbouring viruses with radiolabeled antibodies","volume":"7","author":"Casadevall","year":"2007","journal-title":"Expert Opin. Biol. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2010.08.005_bib0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00003088-199936001-00003","article-title":"Pharmacoscintigraphic evaluation of lung deposition of inhaled zanamivir in healthy volunteers","volume":"36","author":"Cass","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0085","doi-asserted-by":"crossref","first-page":"9810","DOI":"10.1073\/pnas.93.18.9810","article-title":"A candidate live inactivatable attenuated vaccine for AIDS","volume":"93","author":"Chakrabarti","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2010.08.005_bib0090","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1128\/AAC.00211-07","article-title":"RSV604, a novel inhibitor of respiratory syncytial virus replication","volume":"51","author":"Chapman","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0095","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1152\/japplphysiol.01429.2005","article-title":"FDG-PET imaging of pulmonary inflammation in healthy volunteers after airway instillation of endotoxin","volume":"100","author":"Chen","year":"2006","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0100","doi-asserted-by":"crossref","first-page":"L834","DOI":"10.1152\/ajplung.00339.2003","article-title":"Positron emission tomography with [18F]fluorodeoxyglucose to evaluate neutrophil kinetics during acute lung injury","volume":"286","author":"Chen","year":"2004","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0105","doi-asserted-by":"crossref","first-page":"e8142","DOI":"10.1371\/journal.pone.0008142","article-title":"CS-SELEX generates high-affinity ssDNA aptamers as molecular probes for hepatitis C virus envelope glycoprotein E2","volume":"4","author":"Chen","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2010.08.005_bib0110","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2119\/molmed.2009.00014","article-title":"A novel recombinant vaccinia virus expressing the human norepinephrine transporter retains oncolytic potential and facilitates deep-tissue imaging","volume":"15","author":"Chen","year":"2009","journal-title":"Mol. Med."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0115","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01314647","article-title":"Specific neuro-radiological diagnosis of herpes encephalitis in an animal model","volume":"101","author":"Cleator","year":"1988","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0125","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.1371\/journal.pmed.0030427","article-title":"Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins","volume":"3","author":"Dadachova","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0130","doi-asserted-by":"crossref","first-page":"e6297","DOI":"10.1371\/journal.pone.0006297","article-title":"Bacterial thymidine kinase as a non-invasive imaging reporter for Mycobacterium tuberculosis in live animals","volume":"4","author":"Davis","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2010.08.005_bib0135","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/med.20125","article-title":"Selective inhibitors of picornavirus replication","volume":"28","author":"De Palma","year":"2008","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0969-8051(99)00105-5","article-title":"[(11)C]FMAU and [(18)F]FHPG as PET tracers for herpes simplex virus thymidine kinase enzyme activity and human cytomegalovirus infections","volume":"27","author":"de Vries","year":"2000","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0145","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10096-002-0708-2","article-title":"Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases","volume":"21","author":"De Winter","year":"2002","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0150","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0165-6147(89)90266-6","article-title":"Calculating receptor number from binding experiments using same compound as radioligand and competitor","volume":"10","author":"DeBlasi","year":"1989","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2010.02.001","article-title":"Human and viral nucleoside\/nucleotide kinases involved in antiviral drug activation: structural and catalytic properties","volume":"86","author":"Deville-Bonne","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0160","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2008-12-192203","article-title":"Noninvasive in vivo imaging of CD4 cells in simian-human immunodeficiency virus (SHIV)-infected nonhuman primates","volume":"114","author":"Di Mascio","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2010.08.005_bib0165","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1128\/AAC.00419-09","article-title":"Antiretroviral tissue kinetics: in vivo imaging using positron emission tomography","volume":"53","author":"Di Mascio","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0170","doi-asserted-by":"crossref","first-page":"e1007","DOI":"10.1371\/journal.pone.0001007","article-title":"Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET\/CT","volume":"2","author":"Diaz","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2010.08.005_bib0175","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1182\/blood-2003-07-2233","article-title":"Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter","volume":"103","author":"Dingli","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2010.08.005_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2008.05.003","article-title":"Flavivirus methyltransferase: a novel antiviral target","volume":"80","author":"Dong","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0185","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/AAC.49.6.2460-2466.2005","article-title":"Small molecules VP-14637 and JNJ-2408068 inhibit respiratory syncytial virus fusion by similar mechanisms","volume":"49","author":"Douglas","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0190","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0014-5793(03)00635-5","article-title":"Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins","volume":"546","author":"Drummer","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0195","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1177\/135965350801300817","article-title":"Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differently","volume":"13","author":"Duraffour","year":"2008","journal-title":"Antivir. Ther."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2010.08.005_bib0200","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.1086\/520590","article-title":"In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein","volume":"196","author":"Ebihara","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0205","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0969-8051(94)90047-7","article-title":"The application of receptor theory to receptor-binding and enzyme-binding oncologic radiopharmaceuticals","volume":"21","author":"Eckelman","year":"1994","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00004424-200203000-00001","article-title":"Theory and practice of imaging saturable binding sites","volume":"37","author":"Eckelman","year":"2002","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0215","first-page":"350","article-title":"Receptor-binding radiotracers: a class of potential radiopharmaceuticals","volume":"20","author":"Eckelman","year":"1979","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0220","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.drudis.2008.05.009","article-title":"Targeted imaging: an important biomarker for understanding disease progression in the era of personalized medicine","volume":"13","author":"Eckelman","year":"2008","journal-title":"Drug Discov. Today"},{"issue":"Suppl. B","key":"10.1016\/j.antiviral.2010.08.005_bib0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/12.suppl_B.9","article-title":"The biochemistry and mechanism of action of acyclovir","volume":"12","author":"Elion","year":"1983","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0230","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00018-002-8511-x","article-title":"Structure and function of cellular deoxyribonucleoside kinases","volume":"59","author":"Eriksson","year":"2002","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0235","doi-asserted-by":"crossref","unstructured":"Frey, K.A., Albin, R.L., 2001. Receptor binding techniques. Curr. Protoc. Neurosci. Chapter 1, Unit 1\u20134.","DOI":"10.1002\/0471142301.ns0104s00"},{"key":"10.1016\/j.antiviral.2010.08.005_bib0240","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1158\/1078-0432.CCR-06-2295","article-title":"Virus-associated tumor imaging by induction of viral gene expression","volume":"13","author":"Fu","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0245","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0163-7258(92)90006-L","article-title":"Viral thymidine kinases and their relatives","volume":"54","author":"Gentry","year":"1992","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0250","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1517\/14712590802610692","article-title":"Palivizumab: where to from here?","volume":"9","author":"Georgescu","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0255","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.1016\/j.bmcl.2008.08.082","article-title":"Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors","volume":"18","author":"Ghosh","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0260","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/AAC.25.4.476","article-title":"Quantitative uptake studies of 131I-labeled (E)-5-(2-iodovinyl)-2\u2032-deoxyuridine in herpes simplex virus-infected cells in vitro","volume":"25","author":"Gill","year":"1984","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0265","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1182\/blood-2007-01-065573","article-title":"Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene","volume":"110","author":"Goel","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2010.08.005_bib0270","first-page":"1560","article-title":"A tracer kinetic model for 18F-FHBG for quantitating herpes simplex virus type 1 thymidine kinase reporter gene expression in living animals using PET","volume":"45","author":"Green","year":"2004","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0275","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archinte.139.3.286","article-title":"Pulmonary cytomegalovirus infection: detection by Gallium 67 imaging in the transplant patient","volume":"139","author":"Hamed","year":"1979","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0280","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.antiviral.2008.12.003","article-title":"No exit: targeting the budding process to inhibit filovirus replication","volume":"81","author":"Harty","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0285","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nucmedbio.2008.10.008","article-title":"Biodistribution and metabolism of the anti-influenza drug [11C]oseltamivir and its active metabolite [11C]Ro 64-0802 in mice","volume":"36","author":"Hatori","year":"2009","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0290","series-title":"A Manual of Radioactivity","author":"Hevesy","year":"1938"},{"key":"10.1016\/j.antiviral.2010.08.005_bib0295","first-page":"2983","article-title":"Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo","volume":"61","author":"Jacobs","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0300","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.nucmedbio.2004.04.003","article-title":"Experiment assessment of mass effects in the rat: implications for small animal PET imaging","volume":"31","author":"Jagoda","year":"2004","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0305","first-page":"331","article-title":"Analysis of data from \u201ccold saturation\u201d radioligand binding experiments","volume":"73","author":"Jeffries","year":"1997","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0310","first-page":"550","article-title":"Receptor-binding radiopharmaceuticals for imaging breast tumors: estrogen-receptor interactions and selectivity of tissue uptake of halogenated estrogen analogs","volume":"21","author":"Katzenellenbogen","year":"1980","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0315","first-page":"57","article-title":"Penetration of the blood-brain barrier by the antiviral drug (E)-5-(2-iodovinyl)-2\u2032-deoxyuridine in a rat model of herpes encephalitis","volume":"3","author":"Klapper","year":"1988","journal-title":"Drug Des. Deliv."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0320","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bmcl.2008.01.037","article-title":"Radiosyntheses of two positron emission tomography probes: [11C]Oseltamivir and its active metabolite [11C]Ro 64-0802","volume":"18","author":"Konno","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0325","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/CMR.00025-07","article-title":"Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomography","volume":"21","author":"Kumar","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0330","first-page":"325","article-title":"Radiolabeled white blood cells and direct targeting of micro-organisms for infection imaging","volume":"49","author":"Kumar","year":"2005","journal-title":"Q. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.antiviral.2010.08.005_bib0335","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1158\/0008-5472.CAN-06-4062","article-title":"Positron emission tomography of herpes simplex virus 1 oncolysis","volume":"67","author":"Kuruppu","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0340","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature02099","article-title":"An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus","volume":"426","author":"Lamarre","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2010.08.005_bib0345","first-page":"759","article-title":"3\u2032-Deoxy-3\u2032-fluorothymidine, a new selective inhibitor of DNA-synthesis","volume":"23","author":"Langen","year":"1969","journal-title":"Acta Biol. Med. Ger."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0350","doi-asserted-by":"crossref","first-page":"10768","DOI":"10.1128\/JVI.00941-08","article-title":"Identification of a broad-spectrum arenavirus entry inhibitor","volume":"82","author":"Larson","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0355","first-page":"131","article-title":"Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir","volume":"10","author":"Lefebvre","year":"2008","journal-title":"AIDS Rev."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0360","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2008.07.001","article-title":"Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target","volume":"80","author":"Lescar","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0365","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2008.01.004","article-title":"Molecular strategies to inhibit the replication of RNA viruses","volume":"78","author":"Leyssen","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0370","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.nucmedbio.2003.11.006","article-title":"Preparation and pharmacokinetics of 11C labeled stavudine (d4T)","volume":"31","author":"Livni","year":"2004","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0375","first-page":"50","article-title":"Pharmacology of bismuth, with reference to its employment in the therapy of syphilis","volume":"1","author":"Lomholt","year":"1925","journal-title":"Br. J. Vener. Dis."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0380","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1148\/rg.255045122","article-title":"FDG PET of infection and inflammation","volume":"25","author":"Love","year":"2005","journal-title":"Radiographics"},{"key":"10.1016\/j.antiviral.2010.08.005_bib0385","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.rlu.0000135007.33694.a4","article-title":"F-18 fluorodeoxyglucose positron emission tomographic imaging of cytomegalovirus pneumonia","volume":"29","author":"Mackie","year":"2004","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0390","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ymthe.2004.06.158","article-title":"Oncolytic vaccinia virus expressing the human somatostatin receptor SSTR2: molecular imaging after systemic delivery using 111In-pentetreotide","volume":"10","author":"McCart","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0395","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1128\/AAC.29.1.30","article-title":"Oral efficacy of WIN 51711 in mice infected with human poliovirus","volume":"29","author":"McKinlay","year":"1986","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0400","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2967\/jnumed.107.046227","article-title":"Imaging of HSV-tk Reporter gene expression: comparison between [18F]FEAU, [18F]FFEAU, and other imaging probes","volume":"49","author":"Miyagawa","year":"2008","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0405","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2004.12.018","article-title":"Serum antibodies against the hepatitis C virus E2 protein mediate antibody-dependent cellular cytotoxicity (ADCC)","volume":"42","author":"Nattermann","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0410","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.antiviral.2009.02.192","article-title":"A pyrazolotriazolopyrimidinamine inhibitor of bovine viral diarrhea virus replication that targets the viral RNA-dependent RNA polymerase","volume":"82","author":"Paeshuyse","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0415","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.nucmedbio.2008.10.002","article-title":"In vivo site-directed radiotracers: a mini-review","volume":"35","author":"Patel","year":"2008","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0420","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/PL00008465","article-title":"Positron-emission tomography with [18F]fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies","volume":"126","author":"Pauwels","year":"2000","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0425","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1073\/pnas.97.16.9226","article-title":"Inaugural article: positron emission tomography provides molecular imaging of biological processes","volume":"97","author":"Phelps","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2010.08.005_bib0430","doi-asserted-by":"crossref","first-page":"10567","DOI":"10.1128\/JVI.01181-07","article-title":"Molecular determinants of antiviral potency of paramyxovirus entry inhibitors","volume":"81","author":"Porotto","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0435","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/0006-2952(83)90001-1","article-title":"Prospects for the use of radiolabeled antiviral drugs in the diagnosis of herpes simplex encephalitis","volume":"32","author":"Price","year":"1983","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0440","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/rmv.615","article-title":"Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir","volume":"19","author":"Prichard","year":"2009","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0445","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1128\/AAC.01447-06","article-title":"Selective phosphorylation of antiviral drugs by vaccinia virus thymidine kinase","volume":"51","author":"Prichard","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2006.01.013","article-title":"Distinct thymidine kinases encoded by cowpox virus and herpes simplex virus contribute significantly to the differential antiviral activity of nucleoside analogs","volume":"71","author":"Prichard","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0455","doi-asserted-by":"crossref","first-page":"16119","DOI":"10.1073\/pnas.0805240105","article-title":"A noncovalent class of papain-like protease\/deubiquitinase inhibitors blocks SARS virus replication","volume":"105","author":"Ratia","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2010.08.005_bib0460","first-page":"313","article-title":"Gallium-67 lung scintigraphy in patients with acquired immune deficiency syndrome (AIDS)","volume":"68","author":"Reinders Folmer","year":"1986","journal-title":"Eur. J. Respir. Dis."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0465","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11307-004-0954-z","article-title":"Molecular imaging in drug discovery and development: potential and limitations of nonnuclear methods","volume":"7","author":"Rudin","year":"2005","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0470","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ana.410150607","article-title":"Diagnostic imaging of herpes simplex virus encephalitis using a radiolabeled antiviral drug: autoradiographic assessment in an animal model","volume":"15","author":"Saito","year":"1984","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0475","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.nucmedbio.2007.05.009","article-title":"Human reporter genes: potential use in clinical studies","volume":"34","author":"Serganova","year":"2007","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0480","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11307-006-0039-2","article-title":"Positron emission tomography measurement of tumor metabolism and growth: its expanding role in oncology","volume":"8","author":"Shields","year":"2006","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0485","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.virusres.2008.01.002","article-title":"Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors","volume":"134","author":"Sluis-Cremer","year":"2008","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0490","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.vascn.2004.09.001","article-title":"Drug localization and targeting with receptor microscopic autoradiography","volume":"51","author":"Stumpf","year":"2005","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.antiviral.2010.08.005_bib0495","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1021\/jm960718i","article-title":"Synthesis, antiviral activity, and biological properties of vinylacetylene analogs of enviroxime","volume":"40","author":"Victor","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0500","doi-asserted-by":"crossref","first-page":"17970","DOI":"10.1073\/pnas.0406332102","article-title":"Structures of thymidine kinase 1 of human and mycoplasmic origin","volume":"101","author":"Welin","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2010.08.005_bib0505","first-page":"599","article-title":"The effect of 2-desoxy-D-glucose on glycolysis and respiration of tumor and normal tissues","volume":"14","author":"Woodward","year":"1954","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0510","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jmb.2007.02.024","article-title":"Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract","volume":"368","author":"Wu","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0515","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge","volume":"79","author":"Yang","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.08.005_bib0520","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(87)91968-4","article-title":"Response of human-immunodeficiency-virus-associated neurological disease to 3\u2032-azido-3\u2032-deoxythymidine","volume":"1","author":"Yarchoan","year":"1987","journal-title":"Lancet"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354210006923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354210006923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T20:59:13Z","timestamp":1685739553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354210006923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":104,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0166354210006923"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2010.08.005","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}